Short-Term versus Long-Term Mentalization-Based Therapy for Borderline Personality Disorder: A Randomized Clinical Trial (MBT-RCT)
Open accessThe DOI matches its Crossref record; 30 of the 31 references it cites were found in a registry or an index.
Abstract
Introduction: Borderline personality disorder (BPD) is a severe and prevalent psychiatric disorder. Mentalization-based therapy (MBT) is an evidence-based intervention for BPD, and several countries offer treatment programs for BPD lasting for years, which is resource demanding. No previous trial has compared short-term with long-term MBT. Objective: The aim of the study was to assess the efficacy and safety of short-term versus long-term MBT for outpatients with BPD. Methods: Adult outpatients (≥18 years) with subthreshold or diagnosed BPD were randomly assigned (1:1) to short-term MBT (5 months) or long-term MBT (14 months). The primary outcome was BPD symptoms assessed with the Zanarini Rating Scale for Borderline Personality Disorder. Secondary outcomes were functional impairment, quality of life, global functioning, and severe self-harm. All outcomes were primarily assessed at 16 months after randomization. This trial was prospectively registered at ClinicalTrials.gov, NCT03677037. Results: Between October 4, 2018, and December 3, 2020, we randomly assigned 166 participants to short-term MBT (n = 84) or long-term MBT (n = 82). Regression analyses showed no evidence of a difference when assessing BPD symptoms (MD 0.99; 95% CI: −1.06 to 3.03; p = 0.341), level of functioning (MD 1.44; 95% CI: −1.43 to 4.32; p = 0.321), quality of life (MD −0.91; 95% CI: −4.62 to 2.79; p = 0.626), global functioning (MD −2.25; 95% CI: −6.70 to 2.20; p = 0.318), or severe self-harm (RR 1.37; 95% CI: 0.70–2.84; p = 0.335). More participants in the long-term MBT group had a serious adverse event compared with short-term MBT (RR 1.63; 95% CI: 0.94–3.07; p = 0.088), primarily driven by a difference in psychiatric hospitalizations (RR 2.03; 95% CI: 0.99–5.09; p = 0.056). Conclusion: Long-term MBT did not lead to lower levels of BPD symptoms, nor did it influence any of the secondary outcomes compared with short-term MBT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(1998) · The Journal of Clinical Psychiatry · Cited by 19,139
(1998) · PubMed · Cited by 10,216
Validating the SF-36 health survey questionnaire: new outcome measure for primary care.
Brazier, J. E., Harper, R., Jones, N. M., O'Cathain, A., Thomas, K. J., Usherwood, T., & Westlake, L. (1992) · BMJ · doi:10.1136/bmj.305.6846.160 · Cited by 4,653 · cited 1×
“…assessed with the Work and Social Adjustment Scale (WSAS) [20], quality of life assessed with the Short-Form Health Survey (SF-36) mental component [21], global functioning assessed with the Global Assessment of Functioning scale (GAF) [22], and severe self-harm de fi ned as the proportion of…”
MethodJakobsen, J. C., Gluud, C., Wetterslev, J., & Winkel, P. (2017) · BMC Medical Research Methodology · doi:10.1186/s12874-017-0442-1 · Cited by 2,747 · cited 2×
“We used a fi ve-step procedure [24] to assess if the thresholds for statistical and clinical signi fi cance were crossed, and we handled missing data according to the procedure suggested by Jakobsen et al. [25].”
BackgroundMethodSelf-citationBateman, A., & Fonagy, P. (1999) · American Journal of Psychiatry · doi:10.1176/ajp.156.10.1563 · Cited by 1,416
Self-citationDiagnostic and Statistical Manual of Mental Disorders (DSM)
(2009) · Encyclopedia of Health Services Research · doi:10.4135/9781412971942.n109 · Cited by 1,373
Global Assessment of Functioning
Hall, R. C. W. (1995) · Psychosomatics · doi:10.1016/s0033-3182(95)71666-8 · Cited by 975 · cited 1×
“…with the Short-Form Health Survey (SF-36) mental component [21], global functioning assessed with the Global Assessment of Functioning scale (GAF) [22], and severe self-harm de fi ned as the proportion of participants with one or more deliberate act of self-harm resulting in visible tissue damage…”
MethodBateman, A., & Fonagy, P. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09040539 · Cited by 961
Self-citationPsychological therapies for people with borderline personality disorder.
Stoffers-Winterling, J. M., Völlm, B. A., Rücker, G., Timmer, A., Huband, N., & Lieb, K. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005652.pub2 · Cited by 895 · cited 5×
“Second, we assessed both bene fi cial and harmful effects and included objective assessments of serious adverse events, which is rare in psychotherapy trials for BPD [8].”
BackgroundMethodResultInfluentialThe prevalence of DSM-IV personality disorders in psychiatric outpatients
Zimmerman, M., Rothschild, L., & Chelminski, I. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.10.1911 · Cited by 825 · cited 1×
“In clinical populations, it is the most common personality disorder [2], with a prevalence of between 9 and 22% of all psychiatric outpatients [3].”
BackgroundCONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
Schulz, K. F., Altman, D. G., & Moher, D. (2010) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e3181d9d421 · Cited by 519
Psychological therapies for people with borderline personality disorder
Storebø, O. J., Stoffers-Winterling, J. M., Völlm, B. A., Kongerslev, M. T., Mattivi, J. T., Jørgensen, M. S., Faltinsen, E., Todorovac, A., Sales, C. P., Callesen, H. E., et al. (2020) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd012955.pub2 · Cited by 450
Zanarini, M. C. (2003) · Journal of Personality Disorders · doi:10.1521/pedi.17.3.233.22147 · Cited by 413 · cited 2×
“The primary outcome was severity of borderline symptomatology assessed with the ZAN-BPD interview by a blinded as-sessor [16].”
MethodBlum, N., St. John, D., Pfohl, B., Stuart, S., McCormick, B., Allen, J., Arndt, S., & Black, D. W. (2008) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.07071079 · Cited by 407 · cited 1×
“Different short-term psychotherapies exist for patients with BPD, including brief dialectical behavior therapy (DBT) for 20 weeks [33], emotion regulation group therapy (ERGT) for 14 weeks [32], and systems training for emotional predictability and problem solving (STEPPS) for 20 weeks [34].”
BackgroundTreatment of personality disorder
Bateman, A. W., Gunderson, J., & Mulder, R. (2015) · The Lancet · doi:10.1016/s0140-6736(14)61394-5 · Cited by 349 · cited 1×
“Currently, psychological interventions are considered the primary treatment of choice for BPD [5].”
BackgroundSelf-citationLong-term psychodynamic psychotherapy in complex mental disorders: update of a meta-analysis
Leichsenring, F., & Rabung, S. (2011) · British Journal of Psychiatry · doi:10.1192/bjp.bp.110.082776 · Cited by 299 · cited 1×
“These include, but are not limited to, long-term psychodynamic therapy (for complex mental health disorders including BPD) lasting minimum a year [7], dialectical behavior therapy (DBT) up to 1 year, transference-focused psychotherapy (TFP) up to 3 years, schema-focused therapy (SFT) up to 3 years,…”
BackgroundCONSORT 2010 Statement: Updated Guidelines for Reporting Parallel Group Randomized Trials
Schulz, K. F., Altman, D. G., & Moher, D. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-154-4-201102150-00017 · Cited by 259
Methodological Recommendations for Trials of Psychological Interventions
Guidi, J., Brakemeier, E.-L., Bockting, C. L. H., Cosci, F., Cuijpers, P., Jarrett, R. B., Linden, M., Marks, I., Peretti, C. S., Rafanelli, C., et al. (2018) · Psychotherapy and Psychosomatics · doi:10.1159/000490574 · Cited by 205 · cited 1×
“…with the Consolidated Standards of Reporting Trials (CONSORT) 2010 statement [11] (online suppl. material pp. 1 – 2; for all online suppl. material, see https://doi.org/10.1159/000534289) and the methodological recommendations for trials of psychological interventions by Guidi et al. [12].”
BackgroundInfluentialJakobsen, J. C., Gluud, C., Winkel, P., Lange, T., & Wetterslev, J. (2014) · BMC Medical Research Methodology · doi:10.1186/1471-2288-14-34 · Cited by 203 · cited 1×
“We used a fi ve-step procedure [24] to assess if the thresholds for statistical and clinical signi fi cance were crossed, and we handled missing data according to the procedure suggested by Jakobsen et al. [25].”
MethodSelf-citationGratz, K. L., Tull, M. T., & Levy, R. (2014) · Psychological Medicine · doi:10.1017/s0033291713002134 · Cited by 194 · cited 2×
“Different short-term psychotherapies exist for patients with BPD, including brief dialectical behavior therapy (DBT) for 20 weeks [33], emotion regulation group therapy (ERGT) for 14 weeks [32], and systems training for emotional predictability and problem solving (STEPPS) for 20 weeks [34].”
BackgroundMethodMcMain, S. F., Guimond, T., Barnhart, R., Habinski, L., & Streiner, D. L. (2017) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.12664 · Cited by 184 · cited 1×
“Different short-term psychotherapies exist for patients with BPD, including brief dialectical behavior therapy (DBT) for 20 weeks [33], emotion regulation group therapy (ERGT) for 14 weeks [32], and systems training for emotional predictability and problem solving (STEPPS) for 20 weeks [34].”
BackgroundTreatment of Borderline Personality Disorder: Is Supply Adequate to Meet Public Health Needs?
Iliakis, E. A., Sonley, A. K. I., Ilagan, G. S., & Choi-Kain, L. W. (2019) · Psychiatric Services · doi:10.1176/appi.ps.201900073 · Cited by 161 · cited 1×
“Our trial has important practical implications for the treatment of BPD, as the high prevalence of the disorder combined with high costs of existing treatments causes a signi fi cant barrier to accessing evidence-based psychotherapies for BPD in many parts of the world [26].”
BackgroundJuul, S., Gluud, C., Simonsen, S., Frandsen, F. W., Kirsch, I., & Jakobsen, J. C. (2021) · BMJ Evidence-Based Medicine · doi:10.1136/bmjebm-2020-111407 · Cited by 135 · cited 2×
“Trial participants and therapists were not blind to treatment allocation due to the dif fi culties of implementing ef fi cient blinding procedures in trials assessing psychological interventions [17].”
BackgroundMethodSelf-citationPedersen, G., Kvarstein, E. H., & Wilberg, T. (2017) · Personality and Mental Health · doi:10.1002/pmh.1382 · Cited by 90 · cited 1×
“Secondary outcomes were functional impairment assessed with the Work and Social Adjustment Scale (WSAS) [20], quality of life assessed with the Short-Form Health Survey (SF-36) mental component [21], global functioning assessed with the Global Assessment of Functioning scale (GAF) [22], and severe…”
MethodMcMain, S. F., Chapman, A. L., Kuo, J. R., Dixon-Gordon, K. L., Guimond, T. H., Labrish, C., Isaranuwatchai, W., & Streiner, D. L. (2022) · Psychotherapy and Psychosomatics · doi:10.1159/000525102 · Cited by 80 · cited 1×
“The results of our trial are similar to a recent noninferiority trial assessing the effects of 6 versus 12 months of DBT for BPD [35], but this trial assessed the effects of a different intervention and included a narrower participant group, assessing only acute participants (eligibility criteria…”
ResultJørgensen, M. S., Storebø, O. J., Bo, S., Poulsen, S., Gondan, M., Beck, E., Chanen, A. M., BATEMAN, A. W., Pedersen, J., & Simonsen, E. H. (2020) · European Child & Adolescent Psychiatry · doi:10.1007/s00787-020-01551-2 · Cited by 63 · cited 1×
“Similar inclusion criteria have been used in other trials assessing psychotherapy for BPD [31, 32].”
MethodSelf-citationJuul, S., Lunn, S., Poulsen, S., Sørensen, P. S., Salimi, M. L., Jakobsen, J. C., BATEMAN, A. W., & Simonsen, S. (2019) · Trials · doi:10.1186/s13063-019-3306-7 · Cited by 59 · cited 4×
“First, we used a rigorous trial methodology to reduce the risks of bias, and our methodology was prede fi ned in our published protocol and detailed statistical analysis plan prior to un-blinding the results [13, 14].”
BackgroundMethodInfluentialSelf-citationEmployment in borderline personality disorder.
Sansone, R. A., & Sansone, L. A. (2012) · PubMed · Cited by 33
Juul, S., Jakobsen, J. C., Kamp, C. B., Poulsen, S., Sørensen, P. S., & Simonsen, S. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04895-6 · Cited by 29
Self-citationJuul, S., Simonsen, S., Poulsen, S., Lunn, S., Sørensen, P. S., BATEMAN, A. W., & Jakobsen, J. C. (2021) · Trials · doi:10.1186/s13063-021-05450-y · Cited by 19 · cited 5×
“The analyses followed the statistical analysis plan, which was published before unblinding of the data [14].”
BackgroundMethodInfluentialSelf-citation
Research works printed but not linked: 3
- [6]National Institute for Health and Care Excellence (NICE). Borderline personality disorder: recognition and management. Clinical guideline [CG78]. 2009. Available from: https://www.nice.org.uk/guidance/cg78 [accessed September 19, 2022]. 39480982
- [9]Bateman A, Fonagy P. Mentalization-based treatment for personality disorders: a practical guide. Oxford, England: Oxford University Press; 2016.
- [23]International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use). ICH harmonised guideline: integrated addemdum to ICH E6(R1): guideline for good clinical practice (ICH-GCP). 2015.
Cited by
Jørgensen, M. S., Høgenhaug, S. S., Sharp, C., & Bo, S. (2025) · Clinical Psychology & Psychotherapy · doi:10.1002/cpp.70120 · Cited by 16
Self-citationMentalization-Based Treatment for Adolescent Depression
Luyten, P., Malcorps, S., & Fonagy, P. (2024) · Psychodynamic Psychiatry · doi:10.1521/pdps.2024.52.4.490 · Cited by 9
“A recent trial compared 5-and 14-month programs of MBT in adults with marked personality dysfunction and found no differences in treatment outcome, although within-group effect sizes were more modest than in most other trials (Juul et al., 2023).”
Psychotherapies for the treatment of personality disorders: the state of the art
Emmelkamp, P. M. G., & Meyerbröker, K. (2024) · Current Opinion in Psychiatry · doi:10.1097/yco.0000000000000968 · Cited by 9
“In another RCT [27 ] long-term mentalization-based therapy did not lead to lower levels of border-line PD symptoms or other mental health symptoms comparable [28].”
Juul, S., Jakobsen, J. C., Hestbæk, E., Kamp, C. B., Olsen, M. H., Rishede, M., Frandsen, F. W., Bo, S., Poulsen, S., Sørensen, P. S., et al. (2025) · Psychotherapy and Psychosomatics · doi:10.1159/000544934 · Cited by 8
“Three external MBT experts, who were blind to treatment allocation, assessed adherence to the MBT manual in both short-term and long-term MBT using the Mentalization-Based Treatment Adherence and Competence scale [26], yielding good adherence to the manual in both groups [18].”
InfluentialSelf-citationKramer, U., Grandjean, L., Machinea, J. B., Beuchat, H., Ranjbar, S., de Roten, Y., Despland, J., Conus, P., & Kolly, S. (2024) · BMC Psychiatry · doi:10.1186/s12888-024-06370-2 · Cited by 6
Metadata
- Authors
- Juul, S., Jakobsen, J. C., Hestbaek, E., Jørgensen, C. K., Olsen, M. H., Rishede, M., Frandsen, F. W., Bo, S., Lunn, S., Poulsen, S., Sørensen, P., Bateman, A., & Simonsen, S.
- Affiliations
- Mental Health Services (DK)
- University of Southern Denmark (DK)
- Copenhagen University Hospital (DK)
- Region Zealand (DK)
- University of Copenhagen (DK)
- University College London (GB)
- Corresponding author
- Juul, Sophie
- ORCID
- Venue
- Psychotherapy and Psychosomatics
- Publisher
- S. Karger AG
- Published
- 2023
- Volume
- 92
- Issue
- 5
- Pages
- 329-339
- ISSN
- 0033-3190 (ISSN-L)
- 1423-0348
- PMC
- PMC10716869
- OpenAlex
- W4388448724
- Cited by
- 30
- References
- 31
- Citations by year
- 2026: 9 · 2025: 10 · 2024: 10 · 2023: 1
- FWCI
- 8.75
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc
- creativecommons.org/licenses/by-nc/4.0/ (vor)
- creativecommons.org/licenses/by-nc/4.0/ (tdm)
- Locations
- Psychotherapy and Psychosomatics (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by-nc)
- University of Southern Denmark Research Portal (University of Southern Denmark) (publishedVersion, cc-by-nc)
- Funders
- Region Hovedstaden
- TrygFonden (123488)
- Topics
- Social Sciences › Psychology › Clinical Psychology › Personality Disorders and Psychopathology
- Social Sciences › Psychology › Clinical Psychology › Psychotherapy Techniques and Applications
- Social Sciences › Psychology › Clinical Psychology › Psychoanalysis and Psychopathology Research
- Keywords
- borderline personality disorder, mentalization-based treatment, short-term treatment, long-term treatment, treatment duration, treatment efficacy, treatment safety, adverse events, self-harm, quality of life, functional disability, global functioning, outpatients
- MeSH terms
- Mentalization-Based Therapy, Adult, Borderline Personality Disorder, Humans, Outpatients, Quality of Life, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.

